Seoulin Bioscience Co.Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.007x

Seoulin Bioscience Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, Seoulin Bioscience Co.Ltd (038070) has a cash flow conversion efficiency ratio of 0.007x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩631.76 Million ≈ $428.14K USD) by net assets (₩86.05 Billion ≈ $58.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Seoulin Bioscience Co.Ltd (2013–2025)

Cash flow conversion efficiency of Seoulin Bioscience Co.Ltd from 2013 to 2025. This chart illustrates how Seoulin Bioscience Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Seoulin Bioscience Co.Ltd stock quote for real-time trading data and today's change.

Seoulin Bioscience Co.Ltd Cash Flow Conversion Ratio Explained

Seoulin Bioscience Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Seoulin Bioscience Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Seoulin Bioscience Co.Ltd ranked by their cash flow conversion efficiency. Also see Seoulin Bioscience Co.Ltd stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
KPX Lifescience.Co.Ltd KQ:114450	0.095x
Boat Rocker Media Inc TO:BRMI	0.095x
HUTCHMED China Ltd LSE:HCM	0.003x
Dogusan Boru Sanayi ve Ticaret AS IS:DOGUB	-0.014x
Mahalaxmi Rubtech Limited NSE:MHLXMIRU	0.014x
Galaxia SM Inc KO:011420	-0.001x
Transtouch Technology TWO:3623	0.005x
Green Resources Public Company Limited BK:GREEN	0.013x

Annual Cash Flow Conversion Efficiency for Seoulin Bioscience Co.Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Seoulin Bioscience Co.Ltd from 2013 to 2025. Review free cash flow generation of Seoulin Bioscience Co.Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩86.05 Billion ≈ $58.32 Million	₩4.76 Billion ≈ $3.23 Million	0.055x	+200.62%
2024-12-31	₩83.89 Billion ≈ $56.85 Million	₩-4.61 Billion ≈ $-3.13 Million	-0.055x	-590.65%
2023-12-31	₩83.06 Billion ≈ $56.29 Million	₩930.57 Million ≈ $630.63K	0.011x	+121.55%
2022-12-31	₩83.79 Billion ≈ $56.78 Million	₩-4.36 Billion ≈ $-2.95 Million	-0.052x	-143.64%
2021-12-31	₩74.86 Billion ≈ $50.73 Million	₩8.92 Billion ≈ $6.04 Million	0.119x	+93.73%
2020-12-31	₩59.92 Billion ≈ $40.61 Million	₩3.68 Billion ≈ $2.50 Million	0.061x	-49.85%
2019-12-31	₩59.71 Billion ≈ $40.46 Million	₩7.32 Billion ≈ $4.96 Million	0.123x	+57.79%
2018-12-31	₩53.72 Billion ≈ $36.40 Million	₩4.17 Billion ≈ $2.83 Million	0.078x	+207.51%
2017-12-31	₩51.49 Billion ≈ $34.90 Million	₩1.30 Billion ≈ $881.84K	0.025x	-55.42%
2016-12-31	₩48.60 Billion ≈ $32.94 Million	₩2.76 Billion ≈ $1.87 Million	0.057x	-37.62%
2015-12-31	₩45.30 Billion ≈ $30.70 Million	₩4.12 Billion ≈ $2.79 Million	0.091x	+43.12%
2014-12-31	₩43.14 Billion ≈ $29.24 Million	₩2.74 Billion ≈ $1.86 Million	0.063x	-46.57%
2013-12-31	₩41.57 Billion ≈ $28.17 Million	₩4.94 Billion ≈ $3.35 Million	0.119x	--

About Seoulin Bioscience Co.Ltd

KQ:038070 Korea Biotechnology

Market Cap

$21.44 Million

₩31.64 Billion KRW

Market Cap Rank

#24734 Global

#1789 in Korea

Share Price

₩3585.00

Change (1 day)

-1.24%

52-Week Range

₩3565.00 - ₩6940.00

All Time High

₩36786.63